EGR1 Antikörper (AA 282-433)
Kurzübersicht für EGR1 Antikörper (AA 282-433) (ABIN7616364)
Target
Alle EGR1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 282-433
-
Verwendungszweck
- Early Growth Response Protein 1 (EGR1) Monoclonal Antibody
-
Sequenz
- Gln282~Ser433
-
Produktmerkmale
- The Early Growth Response Protein 1 (EGR1) Monoclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
-
Aufreinigung
- Protein A + Protein G affinity chromatography
-
Isotyp
- IgG2a kappa
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- 2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- EGR1 (Early Growth Response 1 (EGR1))
-
Andere Bezeichnung
- EGR1
-
Gen-ID
- 1958
-
UniProt
- P18146
-
Pathways
- Regulation of Carbohydrate Metabolic Process, Regulation of long-term Neuronal Synaptic Plasticity
Target
-